These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8953079)

  • 1. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
    Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
    Kletzel M; Beck S; Elser J; Shock N; Burks W
    Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
    Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous adverse reactions and CD4+ cell counts in human immunodeficiency virus-infected patients receiving trimethoprim-sulfamethoxazole.
    Caumes E
    Clin Infect Dis; 1998 Feb; 26(2):530-2. PubMed ID: 9502502
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
    Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
    Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypersensitivity cross-reaction with dapsone and cotrimoxazole in a patient infected by the human immunodeficiency virus].
    Jiménez-Lozano I; Alcalde M; Campany Herrero D; Monterde J
    Farm Hosp; 2013; 37(4):335-6. PubMed ID: 24010695
    [No Abstract]   [Full Text] [Related]  

  • 8. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Marsh BJ
    Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
    Smith CL; Brown I; Torraca BM
    Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitization.
    Papakonstantinou G; Füessl H; Matuschke A; Hehlmann R
    Klin Wochenschr; 1989 Mar; 67(5):316. PubMed ID: 2785231
    [No Abstract]   [Full Text] [Related]  

  • 11. Life-threatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia.
    Du Plooy N; Rayner B
    S Afr Med J; 2019 Jan; 109(2):89-90. PubMed ID: 30834857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Jung AC; Paauw DS
    Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to trimethoprim-sulfamethoxazole.
    Lee BL
    Clin Rev Allergy Immunol; 1996-1997 Winter; 14(4):451-5. PubMed ID: 9040971
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus.
    Martin GJ; Paparello SF; Decker CF
    Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
    Carr A; Swanson C; Penny R; Cooper DA
    J Infect Dis; 1993 Jan; 167(1):180-5. PubMed ID: 8380290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole-induced renal tubular acidosis in a patient with AIDS.
    Domingo P; Ferrer S; Cruz J; Morla R; Ris J
    Clin Infect Dis; 1995 May; 20(5):1435-7. PubMed ID: 7620045
    [No Abstract]   [Full Text] [Related]  

  • 18. Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS.
    Van Gerpen JA
    Neurology; 1997 Feb; 48(2):537-8. PubMed ID: 9040756
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute delirium induced by intravenous trimethoprim-sulfamethoxazole therapy in a patient with the acquired immunodeficiency syndrome.
    Salkind AR
    Hum Exp Toxicol; 2000 Feb; 19(2):149-51. PubMed ID: 10773846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole associated rhabdomyolysis in a patient with AIDS: case report and review of the literature.
    Walker S; Norwood J; Thornton C; Schaberg D
    Am J Med Sci; 2006 Jun; 331(6):339-41. PubMed ID: 16775445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.